1. Soy Isoflavones and Breast Cancer Cell Lines: Molecular Mechanisms and Future Perspectives
   Alina Uifălean et al, 2015, Molecules CrossRef
2. A novel compound RY10-4 downregulates P-glycoprotein expression and reverses multidrug-resistant phenotype in human breast cancer MCF-7/ADR cells
   Pingping Xue et al, 2014, Biomedicine & Pharmacotherapy CrossRef
3. Dietary Natural Products for Prevention and Treatment of Breast Cancer.
   Ya Li et al, 2017, Nutrients CrossRef
4. Assessing the anticancer effects associated with food products and/or nutraceuticals using in vitro and in vivo preclinical development-related pharmacological tests
   Florence Lefranc et al, 2017, Seminars in Cancer Biology CrossRef
5. Polyphenols, autophagy and doxorubicin-induced cardiotoxicity.
   S Shabalala et al, 2017, Life Sci CrossRef
6. Genistein inhibits the proliferation of human multiple myeloma cells through suppression of nuclear factor-κB and upregulation of microRNA-29b
   JIE XIE et al, 2016 CrossRef
7. Natural Products for the Management and Prevention of Breast Cancer.
   Sarmistha Mitra et al, 2018, Evid Based Complement Alternat Med CrossRef
8. Potential phytocompounds for developing breast cancer therapeutics: Nature’s healing touch
   Javed Iqbal et al, 2018, European Journal of Pharmacology CrossRef
9. Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives
   Muhammad Younas et al, 2018, RSC Adv. CrossRef
10. Phytoestrogens and breast cancer: In vitro anticancer activities of isoflavones, lignans, coumestans, stilbenes and their analogs and derivatives
    Paramita Basu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
11. Prevention of Breast Cancer by Natural Phytochemicals: Focusing on Molecular Targets and Combinational Strategy
    Yi-Shiou Chiou et al, 2018, Mol. Nutr. Food Res. CrossRef
12. The combinatory effects of natural products and chemotherapy drugs and their mechanisms in breast cancer treatment
    Yubo Zhang et al, 2019, Phytochem Rev CrossRef
13. Ampelopsin E Reduces the Invasiveness of the Triple Negative Breast Cancer Cell Line, MDA-MB-231
    Francis Yew Fu Tieng et al, 2019, Molecules CrossRef
14. Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer
    Nethaji Muniraj et al, 2019, Cancers CrossRef
15. Multifunctional hybrid nanoconstructs facilitate intracellular localization of doxorubicin and genistein to enhance apoptotic and anti-angiogenic efficacy in breast adenocarcinoma
    Ravi Prakash Shukla et al, 2020, Biomater. Sci. CrossRef
16. Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer.
    Teodora Costea et al, 2020, Int J Mol Sci CrossRef
17. Adjunct therapeutic potential of phytochemicals against cancer
    Vishal Kumar Gupta et al, 2020 CrossRef
18. Recent Advances of Novel Therapeutic Agents from Botanicals for Prevention and Therapy of Breast Cancer: An Updated Review
    Namrata Singh et al, 2020, CCTR CrossRef
19. Targeting the Key Signaling Pathways in Breast Cancer Treatment Using Natural Agents
    Suresh Kumar Anandasadagopan et al, 2020 CrossRef
20. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066
    Cong-Cong Cheng et al, 2018, Int J Oncol CrossRef
21. ROLE OF FLAVONOIDS AGAINST ADRIAMYCIN TOXICITY
    María D. Navarro-Hortal et al, 2020, Food and Chemical Toxicology CrossRef
22. CYP1B1 as a therapeutic target in cardio-oncology
    Alexa N. Carrera et al, 2020 CrossRef
23. Therapeutic Potential of the Natural Compound S-Adenosylmethionine as a Chemoprotective Synergistic Agent in Breast, and Head and Neck Cancer Treatment: Current Status of Research
    Laura Mosca et al, 2020, IJMS CrossRef
24. Phytoestrogens for Cancer Prevention and Treatment
    Margalida Torrens-Mas et al, 2020, Biology CrossRef
25. Investigating the Anticancer Activity and Characterization of Bioactive Constituents of Moricandia sinaica (Boiss.) Boiss through In Vitro and In Silico Approaches in Triple-Negative Breast Cancer Cell Line
    Muhammad Farooq Khan et al, 2021, Applied Sciences CrossRef
26. Exploration of therapeutic applicability and different signaling mechanism of various phytopharmacological agents for treatment of breast cancer
    Vandana Singh et al, 2021, Biomedicine & Pharmacotherapy CrossRef
27. Vepris macrophylla Essential Oil Produces Notable Antiproliferative Activity and Morphological Alterations in Human Breast Adenocarcinoma Cells
    Marisa Colone et al, 2021, Applied Sciences CrossRef
28. Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits
    Javad Sharifi-Rad et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
29. Natural product-based radiopharmaceuticals: Focus on curcumin and its analogs, flavonoids, and marine peptides.
    Hendris Wongso, 2022, J Pharm Anal CrossRef
30. Neobavaisoflavone May Modulate the Activity of Topoisomerase Inhibitors towards U-87 MG Cells: An In Vitro Study
    Mateusz Maszczyk et al, 2021, Molecules CrossRef
31. Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms
    Paras Famta et al, 2021, Current Research in Pharmacology and Drug Discovery CrossRef
32. Flavonoids Targeting Cancer Stem Cells: A Paradigm to Anticancer Efficacy
    Nahida Siddiqui et al, 2021 CrossRef
33. Screening of metabolites in the treatment of liver cancer xenografts HepG2/ADR by psoralen-loaded lipid nanoparticles
    Lihong Li et al, 2021, European Journal of Pharmaceutics and Biopharmaceutics CrossRef
34. Cytotoxicity of synthetic derivatives against breast cancer and multi-drug resistant breast cancer cell lines: a literature-based perspective study
    Shabnam Sharmin et al, 2021, Cancer Cell Int CrossRef
35. Genistein, a Potential Phytochemical against Breast Cancer Treatment-Insight into the Molecular Mechanisms
    Md Sohel et al, 2022, Processes CrossRef
36. Phloretin-induced suppression of oxidative and nitrosative stress attenuates doxorubicin-induced cardiotoxicity in rats
    ShivaniS Wagh et al, 2022, Asian Pac J Trop Biomed CrossRef
37. Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic Viewpoint
    Md. Rezaul Islam et al, 2022, Molecules CrossRef
38. Natural Products and Their Bioactive Compounds as Breast Cancer Therapeutics
    Monika Rezacova, 2022 CrossRef
39. Chemosensitization of U-87 MG Glioblastoma Cells by Neobavaisoflavone towards Doxorubicin and Etoposide
    Mateusz Maszczyk et al, 2022, IJMS CrossRef
40. Herbal Ingredients in the Prevention of Breast Cancer: Comprehensive Review of Potential Molecular Targets and Role of Natural Products.
    Michael Aschner, 0 CrossRef
41. Role of Plant-Derived Flavonoids in Cancer Treatment
    Prabha Tiwari et al, 2022, Nutrition and Cancer CrossRef
42. Phytochemical Targeting of Mitochondria for Breast Cancer Chemoprevention, Therapy, and Sensitization
    Elizabeth R. M. Zunica et al, 2022, IJMS CrossRef
43. Natural bioactive compounds-doxorubicin combinations targeting topoisomerase II-alpha: Anticancer efficacy and safety
    Ahmed Elfadadny et al, 2023, Toxicology and Applied Pharmacology CrossRef
44. Prognostic significance of natural products against multidrug tumor resistance
    Pankaj Garg et al, 2023, Cancer Letters CrossRef
45. Evaluation of Possible Neobavaisoflavone Chemosensitizing Properties towards Doxorubicin and Etoposide in SW1783 Anaplastic Astrocytoma Cells
    Mateusz Maszczyk et al, 2023, Cells CrossRef
46. Genistein: a promising modulator of apoptosis and survival signaling in cancer
    Hemant Joshi et al, 2023, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
47. In Vitro Effects of Combining Genistein with Aromatase Inhibitors: Concerns Regarding Its Consumption during Breast Cancer Treatment
    Patrícia H. A. Bezerra et al, 2023, Molecules CrossRef
48. Combinatorial Chemosensitive Nanomedicine Approach for the Treatment of Breast Cancer
    Priya Gupta et al, 2023, CMM CrossRef
49. Review on Natural Agents as Aromatase Inhibitors: Management of Breast Cancer
    Sonia Singh, 2024, CCHTS CrossRef
50. Formulation and optimization of transferrin-modified genistein nanocrystals: In vitro anti-cancer assessment and pharmacokinetic evaluation
    Furqan Muhammad Iqbal et al, 2024, International Journal of Pharmaceutics CrossRef
51. Cytotoxic Effects of Plant Secondary Metabolites and Naturally Occurring Bioactive Peptides on Breast Cancer Model Systems: Molecular Mechanisms
    Diana Zasheva et al, 2024, Molecules CrossRef
52. Unleashing the potential of Genistein and its derivatives as effective therapeutic agents for breast cancer treatment
    Eskandar Qaed et al, 2024, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef